tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

GKOS Stock Latest News

Glaukos price target raised to $180 from $140 at Piper Sandler
The FlyGlaukos price target raised to $180 from $140 at Piper Sandler
5d ago
GKOS
Glaukos Highlights Advances in Glaucoma Treatments
PremiumCompany Announcements
Glaukos Highlights Advances in Glaucoma Treatments
18d ago
8K
GKOS
Glaukos says iDose TR showed sustained substantial IOP reductions in Phase 3
PremiumThe Fly
Glaukos says iDose TR showed sustained substantial IOP reductions in Phase 3
18d ago
GKOS
Glaukos price target raised to $157 from $149 at BTIG
PremiumThe Fly
Glaukos price target raised to $157 from $149 at BTIG
29d ago
GKOS
Glaukos price target raised to $175 from $153 at Stifel
PremiumThe Fly
Glaukos price target raised to $175 from $153 at Stifel
1M ago
GKOS
Glaukos submits NDA to U.S. FDA for Epioxa to treat keratoconus
PremiumThe FlyGlaukos submits NDA to U.S. FDA for Epioxa to treat keratoconus
1M ago
GKOS
Glaukos price target raised to $185 from $152 at Truist
Premium
The Fly
Glaukos price target raised to $185 from $152 at Truist
1M ago
GKOS
Reddit initiated, GE Vernova downgraded: Wall Street’s top analyst calls
Premium
The Fly
Reddit initiated, GE Vernova downgraded: Wall Street’s top analyst calls
2M ago
BE
GD
Glaukos upgraded to Buy from Neutral at Citi
PremiumThe Fly
Glaukos upgraded to Buy from Neutral at Citi
2M ago
GKOS
Buy/Sell: Wall Street’s top 10 stock calls this week
PremiumThe Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
2M ago
DG
NU
Shopify upgraded, Deere downgaded: Wall Street’s top analyst calls
PremiumThe Fly
Shopify upgraded, Deere downgaded: Wall Street’s top analyst calls
2M ago
DE
DG
Glaukos initiated with a Buy at UBS
PremiumThe Fly
Glaukos initiated with a Buy at UBS
2M ago
GKOS
Tesla upgraded, Autodesk initiated: Wall Street’s top analyst calls
PremiumThe FlyTesla upgraded, Autodesk initiated: Wall Street’s top analyst calls
2M ago
S
NU
Glaukos price target raised to $153 from $145 at Stifel
Premium
The Fly
Glaukos price target raised to $153 from $145 at Stifel
2M ago
GKOS
Glaukos downgraded to Underweight from Equal Weight at Morgan Stanley
Premium
The Fly
Glaukos downgraded to Underweight from Equal Weight at Morgan Stanley
2M ago
GKOS
Glaukos price target raised to $149 from $140 at BTIG
PremiumThe Fly
Glaukos price target raised to $149 from $140 at BTIG
2M ago
GKOS
Glaukos Revolutionizes Glaucoma Treatment with iDose TR Approval
PremiumCompany Announcements
Glaukos Revolutionizes Glaucoma Treatment with iDose TR Approval
3M ago
8K
GKOS
Glaukos price target raised to $140 from $139 at BTIG
PremiumThe Fly
Glaukos price target raised to $140 from $139 at BTIG
3M ago
GKOS
Glaukos price target raised to $145 from $135 at Wells Fargo
PremiumThe Fly
Glaukos price target raised to $145 from $135 at Wells Fargo
3M ago
GKOS
Glaukos Corp. Reports Record Third-Quarter Sales Growth
PremiumCompany AnnouncementsGlaukos Corp. Reports Record Third-Quarter Sales Growth
3M ago
GKOS
Closing Bell Movers: Palantir jumps 13% after results
Premium
The Fly
Closing Bell Movers: Palantir jumps 13% after results
3M ago
CE
MQ
Glaukos reports Q3 adjusted EPS (28c), consensus (48c)
Premium
The Fly
Glaukos reports Q3 adjusted EPS (28c), consensus (48c)
3M ago
GKOS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >